Exercise Intervention for Blood Pressure Reduction in Diabetic Patients: A Systematic Review and Meta-Analysis
Abstract
Diabetes is a disease that occurs when the blood glucose is too high in the body. The disease has become a deadly epidemic due to its widespread and increasing prevalence. With the increasing prevalence of diabetic cases globally, and most especially in the United States of America, there is an urgent need to manage the disease by assessing the impact of exercise on blood pressure reduction in a diabetic patient. An electronic search was conducted in PubMed and Google Scholar for studies published between January 2005 and December 2023. The meta-analysis was performed without any restriction on patients' gender, demographics, and ethnicity. The finding was reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PRISMA) checklist. Six studies met the inclusion criteria for meta-analysis. Our result showed that the intervention group significantly caused a reduction in systolic blood pressure (SMD = -0.12 mmHg, 95% CI, -0.58 to 0.35; tau square = 0.3790; p < 0.0001) and diastolic blood pressure (SMD = -1.29 mmHg, 95% CI, -2.49 to -0.08; tau square = 2.9214; p < 0.0001) in patients with diabetes. The review demonstrated that regular exercise could positively impact patient health status and reduce the risk of death.
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.